HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.
5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Heart Transplantation
Heart Transplantation
It is the serious player It is a surgical procedure in which a flawed or dented heart is supplanted by a healthy and nutritious donor heart that has recently died. If a patient has a heart problem and is unable to recover from treatment, heart transplant procedures are performed.
Risk:
- Denial of the patient's heart.
- Primary graft inability
- Issue if the arteries are not removed.
- Medication side impacts
- Cancer.
Infection control by injecting medicines straight into the bone marrow, creating a pro point of entry into the institutional venous system. Once intravenous entrance is not available, this technique is used to enable fluids and medication. It is also a crucial component of the hospital's intensive care unit when there is an emergency.
Committee Members
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Syed Raza
Awali Hospital, Bahrain Heart Congress 2027 Speakers
Federico Benetti
Benetti Foundation, Argentina
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Syed Raza
Awali Hospital, Bahrain
Uwe Peter Tigor
Auxilius Pharma, United StatesSubmit your abstract Today
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India